Filtration Fraction Calculation CRRT
Estimate filtration fraction (FF) in continuous renal replacement therapy to support circuit longevity and safer hemofilter operation.
Expert Guide to Filtration Fraction Calculation in CRRT
Filtration fraction (FF) is one of the most important practical parameters in continuous renal replacement therapy (CRRT), especially for teams using convective strategies such as CVVH or mixed techniques such as CVVHDF. At the bedside, FF helps clinicians estimate how aggressively plasma water is being removed as blood passes through the hemofilter. That matters because high FF leads to hemoconcentration inside the filter, and hemoconcentration directly increases the risk of premature circuit clotting, therapy interruption, blood loss, nursing workload, and cost.
In simple terms, FF is the proportion of plasma water entering the filter that gets ultrafiltered. A lower FF usually means lower intrafilter hemoconcentration and better circuit life. A very high FF can indicate a setup that is technically possible but operationally unstable over long ICU runs. Many programs target FF around 20% and usually keep it below 25% in post-dilution setups. Pre-dilution often allows higher replacement rates at the same clotting risk because prefilter dilution reduces viscosity at the membrane interface.
Core Formula and How This Calculator Applies It
The standard bedside concept is:
- Filtration Fraction (%) = (Total ultrafiltration rate / Plasma water flow into filter) × 100
In practical units:
- Convert hourly flows to mL/min.
- Compute plasma water flow from blood flow and hematocrit.
- Add prefilter replacement flow to denominator when replacement is prefilter.
- Use total convective ultrafiltration in the numerator (replacement plus net fluid removal).
This calculator uses:
- Plasma water flow = Qb × (1 – Hct) for post-dilution.
- Plasma water flow = Qb × (1 – Hct) + prefilter replacement flow for pre-dilution.
- Total UF = replacement rate + net UF goal (converted to mL/min).
Even when a unit runs CVVHDF, this FF estimate remains useful to quantify the convective load and clotting risk pressure related to ultrafiltration across the membrane.
Why Filtration Fraction Matters Clinically
ICU teams focus on delivered dose, hemodynamic tolerance, and fluid balance, but circuit survival is a major quality determinant. Every filter clot reduces delivered therapy and may increase downtime. FF offers a rapid, objective way to proactively tune settings before clotting becomes recurrent. It is especially important in patients with high hematocrit, rising fibrinogen, inflammatory states, or low blood flow access limitations.
- High FF increases intrafilter protein and cellular concentration.
- Hemoconcentration increases transmembrane pressure and clot propensity.
- Frequent clotting reduces effective dose and worsens treatment continuity.
- Lowering FF can improve filter life without changing the overall clinical fluid goal.
Landmark CRRT Trial Data and Dose Context
While FF itself was not the primary endpoint in major dose-intensity trials, those studies strongly shaped modern CRRT flow prescriptions and reinforced that more intensive clearance does not automatically improve mortality. This matters because pushing high convective rates without considering FF can create technical instability without proven survival benefit.
| Trial | Sample Size | Intervention | Primary Mortality Result | Clinical Takeaway |
|---|---|---|---|---|
| ATN Study (NEJM 2008) | 1,124 critically ill adults | Intensive vs less-intensive renal support strategy | 60-day mortality: 53.6% vs 51.5% (no significant benefit) | Escalating intensity alone did not improve survival. |
| RENAL Study (NEJM 2009) | 1,508 ICU patients | Higher effluent dose 40 vs 25 mL/kg/hr | 90-day mortality: 44.7% vs 44.5% (no significant difference) | Standard dosing remained appropriate; operational quality became central. |
In modern practice, this evidence supports balancing prescription ambition with circuit reliability. Filtration fraction management is one of the most direct ways to achieve that balance.
Practical FF Targets and Circuit Risk Zones
Many bedside protocols categorize FF as a technical risk marker rather than an absolute stopping rule. The exact threshold can vary by anticoagulation strategy, catheter performance, membrane type, and dilution mode, but the following framework is widely used:
| Filtration Fraction Range | Typical Interpretation | Operational Implication |
|---|---|---|
| < 20% | Conservative zone | Usually favorable for filter survival when other factors are optimized. |
| 20% to 25% | Caution zone | Commonly acceptable, but monitor transmembrane pressure and filter trend closely. |
| > 25% | Higher clotting risk zone | Consider lowering convective load, increasing Qb, shifting to pre-dilution, or revisiting anticoagulation. |
How to Reduce an Elevated Filtration Fraction
If your calculated FF is high, several interventions can reduce clot risk without abandoning treatment goals:
- Increase blood flow (Qb) when vascular access allows. This raises plasma water flow denominator and lowers FF.
- Move replacement fluid to pre-dilution. Predilution reduces intrafilter hematocrit and lowers effective filtration stress.
- Reduce replacement rate if clinically acceptable, especially when high convective clearance is not mandatory.
- Reassess net fluid removal speed and spread goals over longer treatment time if hemodynamics permit.
- Optimize anticoagulation strategy, often including regional citrate protocols where available and appropriate.
Importantly, these changes should be integrated with patient-level context: shock state, citrate metabolism risk, bleeding risk, access performance, and planned duration of therapy.
Step-by-Step Example
Suppose your settings are:
- Qb = 180 mL/min
- Hct = 30% (0.30)
- Replacement = 1,500 mL/hr
- Net UF = 100 mL/hr
- Post-dilution mode
First, plasma water flow in post-dilution:
Qpw = 180 × (1 – 0.30) = 126 mL/min
Total ultrafiltration:
Quf = (1500 + 100) / 60 = 26.7 mL/min
Filtration fraction:
FF = 26.7 / 126 × 100 = 21.2%
Interpretation: this is in a caution but commonly acceptable range. You would typically monitor pressure trends and circuit life. If recurrent clotting occurs, lowering FF toward or below 20% may improve uptime.
Common Pitfalls in FF Calculation
- Ignoring dilution mode: using the post-dilution denominator during pre-dilution overestimates risk.
- Unit mismatch: mixing mL/hr and mL/min leads to major errors.
- Using effluent total without context: dialysate flow contributes to dose, but not directly to convective FF stress.
- Forgetting hematocrit updates: transfusions or bleeding events can materially change FF.
- Treating FF as the only clot predictor: anticoagulation adequacy, access quality, and inflammation still matter.
How FF Fits into Broader CRRT Quality Metrics
High-performing programs do not rely on one number. They combine FF tracking with delivered effluent dose, circuit life, downtime, alarm burden, and net ultrafiltration achievement. This integrated approach is especially important because ICU physiology is dynamic. A prescription that was stable overnight may become unstable after vasopressor escalation, catheter dysfunction, or rapid hematocrit changes.
Many units embed FF checks into nursing and nephrology rounds:
- At CRRT initiation
- After major flow changes
- After repeated circuit clotting
- At shift handoff in unstable patients
This process helps avoid reactive troubleshooting and supports more predictable treatment delivery.
Evidence-Informed External References
For deeper clinical review, these authoritative resources are useful:
- NIH PubMed: ATN Study (Intensive vs Less-Intensive Renal Support in AKI)
- NIH PubMed: RENAL Study (Higher vs Lower Intensity CRRT)
- NIDDK (.gov): Acute Kidney Injury Overview
Bottom Line
Filtration fraction calculation in CRRT is a high-value bedside tool. It gives immediate operational insight into whether your filter is being pushed toward hemoconcentration and clot risk. In day-to-day ICU care, an FF-centered adjustment strategy can improve circuit survival, reduce interruptions, and preserve delivered dose without unnecessary escalation in intensity. Use FF with clinical context, pressure trends, and anticoagulation strategy for the safest and most durable CRRT performance.